(0.44%) 5 068.50 points
(0.30%) 38 184 points
(0.54%) 17 533 points
(0.57%) $79.45
(1.45%) $1.960
(0.51%) $2 322.70
(0.14%) $26.79
(1.34%) $967.70
(0.02%) $0.933
(0.08%) $11.04
(-0.04%) $0.798
(-0.93%) $92.39
0.54% HKD 11.20
Live Chart Being Loaded With Signals
Shanghai Pharmaceuticals Holding Co., Ltd., an investment holding company, researches, develops, manufactures, distributes, and retails pharmaceutical and healthcare products in the People's Republic of China...
Stats | |
---|---|
Volumen de hoy | 1.32M |
Volumen promedio | 2.41M |
Capitalización de mercado | 57.43B |
EPS | HKD0.320 ( 2023-10-27 ) |
Last Dividend | HKD0.664 ( 2023-07-18 ) |
Next Dividend | HKD0 ( N/A ) |
P/E | 10.09 |
ATR14 | HKD0.0110 (0.10%) |
Volumen Correlación
Shanghai Pharmaceuticals Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Shanghai Pharmaceuticals Correlación - Moneda/Commodity
Shanghai Pharmaceuticals Finanzas
Annual | 2023 |
Ingresos: | HKD260.30B |
Beneficio Bruto: | HKD31.33B (12.04 %) |
EPS: | HKD1.020 |
FY | 2023 |
Ingresos: | HKD260.30B |
Beneficio Bruto: | HKD31.33B (12.04 %) |
EPS: | HKD1.020 |
FY | 2022 |
Ingresos: | HKD231.98B |
Beneficio Bruto: | HKD30.49B (13.14 %) |
EPS: | HKD1.610 |
FY | 2021 |
Ingresos: | HKD215.82B |
Beneficio Bruto: | HKD28.54B (13.23 %) |
EPS: | HKD1.790 |
Financial Reports:
No articles found.
Shanghai Pharmaceuticals Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0.984 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0.664 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | HKD0.196 | 2012-06-14 |
Last Dividend | HKD0.664 | 2023-07-18 |
Next Dividend | HKD0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 13 | -- |
Total Paid Out | HKD5.57 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.97 | -- |
Div. Sustainability Score | 9.96 | |
Div.Growth Potential Score | 5.66 | |
Div. Directional Score | 7.81 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
2885.HK | Ex Dividend Junior | 2023-06-15 | Annually | 0 | 0.00% | |
1501.HK | Ex Dividend Junior | 2023-05-24 | Annually | 0 | 0.00% | |
0552.HK | Ex Dividend Junior | 2023-07-03 | Annually | 0 | 0.00% | |
8062.HK | Ex Dividend Knight | 2023-08-17 | Annually | 0 | 0.00% | |
2003.HK | Ex Dividend Junior | 2023-10-17 | Annually | 0 | 0.00% | |
1075.HK | Ex Dividend Junior | 2023-06-20 | Annually | 0 | 0.00% | |
0151.HK | Ex Dividend Knight | 2023-08-24 | Semi-Annually | 0 | 0.00% | |
3688.HK | No Dividend Player | 2023-05-25 | Annually | 0 | 0.00% | |
1650.HK | Ex Dividend Junior | 2023-06-05 | Annually | 0 | 0.00% | |
0688.HK | Ex Dividend Knight | 2023-09-18 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0144 | 1.500 | 9.71 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0174 | 1.200 | 9.42 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0553 | 1.500 | -0.497 | -0.745 | [0.1 - 1] |
payoutRatioTTM | 1.029 | -1.000 | 10.00 | -10.00 | [0 - 1] |
currentRatioTTM | 1.336 | 0.800 | 8.32 | 6.65 | [1 - 3] |
quickRatioTTM | 1.058 | 0.800 | 8.48 | 6.78 | [0.8 - 2.5] |
cashRatioTTM | 0.240 | 1.500 | 9.78 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.226 | -1.500 | 6.23 | -9.35 | [0 - 0.6] |
interestCoverageTTM | 4.07 | 1.000 | 9.60 | 9.60 | [3 - 30] |
operatingCashFlowPerShareTTM | 2.14 | 2.00 | 9.29 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 1.281 | 2.00 | 9.36 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.701 | -1.500 | 7.20 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.116 | 1.000 | -1.395 | -1.395 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0287 | 1.000 | -1.425 | -1.425 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.160 | 1.000 | -0.223 | -0.223 | [0.2 - 2] |
assetTurnoverTTM | 1.215 | 0.800 | 5.23 | 4.19 | [0.5 - 2] |
Total Score | 9.96 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 9.79 | 1.000 | 9.11 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0553 | 2.50 | -0.319 | -0.745 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 1.281 | 2.00 | 9.57 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 6.57 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 2.14 | 2.00 | 9.29 | 10.00 | [0 - 30] |
payoutRatioTTM | 1.029 | 1.500 | 10.00 | -10.00 | [0 - 1] |
pegRatioTTM | 2.12 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0297 | 1.000 | -1.757 | 0 | [0.1 - 0.5] |
Total Score | 5.66 |
Shanghai Pharmaceuticals
Shanghai Pharmaceuticals Holding Co., Ltd., an investment holding company, researches, develops, manufactures, distributes, and retails pharmaceutical and healthcare products in the People's Republic of China. It operates through four segments: Production, Distribution, Retail, and Others. The company offers chemicals and biochemicals, Chinese medicines, healthcare products, and medical devices in various therapeutic areas, including oncology, cerebrocardiovascular, CNS, general infection, immunology, digestive and metabolism, and respiratory. It provides approximately 700 varieties of drugs. The company also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it engages in the operation of a network of retail pharmacy stores; online drug business; and provision of consulting services, assets management operations, as well as clinical trials, medical aid, physicians and patients' education, e-prescription management, and remote and cloud hospitals. Further, the company manufactures and trades in medicines. It operates approximately 2,000 retail chain pharmacies in 24 provinces. The company was incorporated in 1994 and is headquartered in Shanghai, the People's Republic of China. Shanghai Pharmaceuticals Holding Co., Ltd. is a subsidiary of Shanghai Pharmaceutical (Group) Co., Ltd.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico